Wide-field OCTA quantified peripheral nonperfusion areas predict the risk of subclinical neovascularization
- 2 July 2025
- journal article
- research article
- Published by Springer Nature in Eye
- Vol. 39 (12) , 2467-2473
Abstract
Purpose To demonstrate the capabilities of single-shot widefield swept-source OCT angiography (SS-OCTA) in detecting subclinical retinal neovascularization (RNV), quantifying nonperfusion areas (NPAs), and exploring the relations between NPAs and subclinical RNV in eyes graded as nonproliferative diabetic retinopathy (NPDR). Methods Eyes clinically graded as moderate to severe NPDR underwent SS-OCTA imaging. Expert graders identified subclinical RNV, defined as vessels with a flow signal above the internal limiting membrane on OCTA that are not visible on dilated fundus examination. This identification was based on a combination of en face OCT, en face OCTA, and cross-sectional OCTA overlaid on OCT. NPA index was calculated as a percentage of automatically quantified NPA over the area in the posterior pole, the mid-periphery, and the total imaged area. Results Totally 37 eyes, including 21 had severe NPDR and 16 had moderate NPDR. Subclinical RNV was present in 14 eyes (37.8%). The eyes with RNV had significantly higher mid-peripheral and total NPA indices but not in the posterior region (mid-peripheral NPA: 31.97% ± 7.02% vs. 24.80% ± 6.60%, p = 0.041; total NPA: 27.96% ± 6.36% vs. 21.61% ± 5.65%, p = 0.046; all values are reported as mean ± standard deviation). The total NPA index showed the highest diagnostic accuracy for subclinical RNV detection (AUC: 0.761; 95% CI, 0.592–929, with a sensitivity of 64.3% and a specificity of 87% at a cutoff value of 28.84%). Conclusion Widefield SS-OCTA can detect subclinical RNV. The eyes with higher mid-peripheral NPA indices are more likely to have subclinical RNV, indicating that the NPA index may be a useful biomarker for identifying eyes at risk of RNV.Keywords
All Related Versions
This publication has 37 references indexed in Scilit:
- Prevalence of Diabetic Retinopathy in the US in 2021JAMA Ophthalmology, 2023
- Quantification of Retinal Nonperfusion and Neovascularization With Ultrawidefield Fluorescein Angiography in Patients With Diabetes and Associated Characteristics of Advanced DiseaseJAMA Ophthalmology, 2020
- Optical Coherence Tomography Angiography Avascular Area Association With 1-Year Treatment Requirement and Disease Progression in Diabetic RetinopathyAmerican Journal of Ophthalmology, 2020
- Distribution of Diabetic Neovascularization on Ultra-Widefield Fluorescein Angiography and on Simulated Widefield OCT AngiographyAmerican Journal of Ophthalmology, 2019
- Retinal Nonperfusion Characteristics on Ultra-Widefield Angiography in Eyes With Severe Nonproliferative Diabetic Retinopathy and Proliferative Diabetic RetinopathyJAMA Ophthalmology, 2019
- Guidelines on Diabetic Eye CareOphthalmology, 2018
- Automated Quantification of Capillary Nonperfusion Using Optical Coherence Tomography Angiography in Diabetic RetinopathyJAMA Ophthalmology, 2016
- Validation of Concentric Rings Method as a Topographic Measure of Retinal Nonperfusion in Ultra-Widefield Fluorescein AngiographyAmerican Journal of Ophthalmology, 2015
- Diabetic Retinopathy Severity and Peripheral Lesions Are Associated with Nonperfusion on Ultrawide Field AngiographyOphthalmology, 2015
- Global estimates of the prevalence of diabetes for 2010 and 2030Diabetes Research and Clinical Practice, 2010